|

Diabetes Clinical Trials in Indianapolis, IN

37 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 YearsN/A<1 mi
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)Phase 3<1 mi
Mechanisms Underlying Impaired Diabetic Wound Healing—<1 mi
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With DiabetesN/A<1 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)Phase 1/2<1 mi
Type 1 Diabetes Extension Study—<1 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 DiabetesPhase 2<1 mi
Intensive Glycemic Targets in Overweight and Obese Women With Gestational DiabetesN/A<1 mi
TrialNet Pathway to Prevention of T1D—<1 mi
Denosumab for Type 1 DiabetesPhase 1/2<1 mi
Drug Interaction Potential of Pro-Inflammatory Conditions—<1 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesPhase 3<1 mi
CGM Dynamic Index for Predicting Prediabetes in Cystic FibrosisN/A<1 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 DiabetesPhase 2<1 mi
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot TrialN/A<1 mi
Registry for Stage 2 Type 1 Diabetes—<1 mi
Rare and Atypical Diabetes Network—<1 mi
To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.N/A<1 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms—<1 mi
CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW PopulationsN/A<1 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesPhase 3<1 mi
Fenofibrate for Prevention of DR WorseningPhase 3<1 mi
Biomarker of Diabetic Retinopathy—<1 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)Phase 3<1 mi
Monitoring Exhaled Breath to Noninvasively Detect Glycemic EventsN/A<1 mi
T1D Pregnancy & Me—<1 mi
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin ActionPhase 2<1 mi
Bionic Pancreas in CFRDPhase 3<1 mi
TArgeting Type 1 Diabetes Using POLyamines (TADPOL)Phase 2<1 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics—<1 mi
Enhancing Shared Decision-making to Guide Care for People With Dementia and DiabetesN/A<1 mi
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)Phase 3<1 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/A<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePhase 313 mi
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatidePhase 214 mi
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)—15 mi
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseasePhase 315 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.